Article Versions Notes

Wróblewska KB, Milanowski B, Kucińska M, Plewa S, Długaszewska J, Muszalska-Kolos I. Novel Formulation of Eye Drops Containing Choline Salicylate and Hyaluronic Acid: Stability, Permeability, and Cytotoxicity Studies Using Alternative Ex Vivo and In Vitro Models. Pharmaceuticals. 2021; 14(9):849. https://doi.org/10.3390/ph14090849

Wróblewska, Katarzyna Barbara, Bartłomiej Milanowski, Małgorzata Kucińska, Szymon Plewa, Jolanta Długaszewska, and Izabela Muszalska-Kolos. 2021. "Novel Formulation of Eye Drops Containing Choline Salicylate and Hyaluronic Acid: Stability, Permeability, and Cytotoxicity Studies Using Alternative Ex Vivo and In Vitro Models" Pharmaceuticals 14, no. 9: 849. https://doi.org/10.3390/ph14090849

Wróblewska, K. B., Milanowski, B., Kucińska, M., Plewa, S., Długaszewska, J., & Muszalska-Kolos, I. (2021). Novel Formulation of Eye Drops Containing Choline Salicylate and Hyaluronic Acid: Stability, Permeability, and Cytotoxicity Studies Using Alternative Ex Vivo and In Vitro Models. Pharmaceuticals, 14(9), 849. https://doi.org/10.3390/ph14090849